U.S. Court of Appeals for the Federal Circuit, 2012

Allergan, Inc. v. Watson Laboratories, Inc. -Florida

Allergan, Inc. v. Watson Laboratories, Inc. -Florida
U.S. Court of Appeals for the Federal Circuit · Decided May 1, 2012

Allergan, Inc. v. Watson Laboratories, Inc. -Florida

Opinion

NOTE: This order is nonprecedential United States Court of AppeaIs for the FederaI Circuit ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, ENDO PHARMACEUTICALS SOLUTIONS, INC., AND SUPERNUS PHARM_ACEUTICALS, INC., Plaintiffs-Appellants, V. WATSON LABORATORIES, INC. - FLORIDA, Defenclant-Appellee, _ AND SANDOZ, INC., Defendcmt-Appellee, AND PADDOCK LA.BORATORIES, INC., Defendant-Appellee.

2012-1310 Appea1 from the United States District C0urt for the District of De1aWare in consolidated case n0. 09-CV-0511, Chief Judge Greg0ry M. S1eet.

ON MOTION ALLERGAN V. WATSON LABS 2 ORDER Sandoz Inc. moves for reconsideration of this court's Apri1 27, 2012 order expediting the briefing schedu1e.

Upon consideration thereof IT Is ORDERED THAT: The motion for reconsideration is denied FOR THE CoURT MAY 0 1 2012 /sf Jan Horbaly Date J an Horbaly C1erk cc: Jonathan E. Singer, Esq.

Char1es A. Weiss, Esq.

Deanne E. Maynard, Esq.

F|LED wendy M' Wa”d’ ESq' u.s.`coun1m=APPeALsF0n msFznsnALc1ncu\1 mm 01201z JAN HURBA|.V CI.ERK

Case-law data current through December 31, 2025. Source: CourtListener bulk data.